• Colleen Nixon
Part of the Pediatric Oncology book series (PEDIATRICO, volume 22)


Hearing Loss Hair Cell Aminoglycoside Antibiotic Pediatric Oncology Patient Ototoxic Agent 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. American Cancer Society. Retrieved 12/30/03Google Scholar
  2. Berg A.L., Spitzer J.B., Garvin J.H. (1999) Ototoxic impact of cisplatin in pediatric oncology patients. Laryngoscope 109(11):1806–1814PubMedGoogle Scholar
  3. Brookhouser P.E. (2002) Diseases of the inner ear and sensorineural hearing. In: Bluestone C.D., Casselbrant M.L., Stool S.E., Dohar J.E., Alper C.M., Arjmand E.M., Yellon R.F. (eds) Pediatric Otolaryngology, 4th edn. Philadelphia: Saunders, pp.798–800Google Scholar
  4. Children’s Oncology Group. Healthy living after treatment for childhood cancer. Retrieved 1/5/04Google Scholar
  5. Cunningham M., Cox E.O. (2003) Hearing assessment in infants and children: Recommendation beyond neonatal screening. Pediatrics 111(2):436–440PubMedGoogle Scholar
  6. Gradishar W.J., Stephenson P., Glover D.J., Neuber D.S., Moore M.R., Windschiti H.E., et al. (2001) A phase II trial of cisplatin plus WR-2721 (amifostine) for metastatic breast carcinoma: An eastern cooperative oncology study (E8188). Cancer 92(10):2517–2522PubMedGoogle Scholar
  7. Halperin E.C., Constine L.S., Tarbell N.J., Kun L.E. (eds) (1999) Late effects of cancer treatment. In: Pediatric Oncology, 3rd edn. Philadelphia: Lippincott Williams & Wilkins, pp. 515–517Google Scholar
  8. Huang E., Teh B.S., Strother D.R., Davis Q.G., Chiu, J.K., Lu H.H. (2002) Intensity-modulated radiation therapy for pediatric medulloblastoma: Early report on the reduction of ototoxicity. International Journal of Radiation Oncology, Biology, Physics 52(3):599Google Scholar
  9. Kline N.E., Bloom D (2003) The child with cognitive, sensory, or communication impairment. In: Hockenberry M.J., Wilson D., Winkelstein M., Kline N.E. (eds.) Wong’s Nursing Care of Infants and Children,7th edn. St. Louis: Mosby, pp.994–997Google Scholar
  10. Landier W. (1998) Hearing loss related to ototoxicity in children with cancer. Journal of Pediatric Oncology 15(4):195–207Google Scholar
  11. Matz G. (1993) Aminoglycoside cochlear ototoxicity. Otolaryngologic Clinics of North America 26(5):705–711PubMedGoogle Scholar
  12. Meyer M.A. (2001) Neurotoxicity of chemotherapy agents. In: Perry M.C. (ed) The Chemotherapy Source Book. Philadelphia: Lippincott Williams & Wilkins, pp. 504–509Google Scholar
  13. National Cancer Institute. Late effects of childhood cancer. Retrieved 12/30/03Google Scholar
  14. Michaud L.J., Ried S.R., McMahon M.A. (2002) Rehabilitation of the child with cancer. In: Pizzo P.A., Poplak D.G. (eds) Principles and Practice of Pediatric Oncology. Philadelphia: Lippincott Williams & Wilkins, p. 1356Google Scholar
  15. Parsons S.K, Neault M.W., Lehmann L.E., Brennan L.L., Eickhoff C.E., Kretschmar C.S., Diller L.R. (1998) Severe ototoxicity following carboplatin-containing conditioning regimen for autologous marrow transplantation for neuroblastoma. Bone Marrow Transplantation 22:669–674PubMedGoogle Scholar
  16. Schell M. J., McHaney V.A, Green A.A., Kun L.E., Hayes A., Horowitz M., et al. (1989) Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation. Journal of Clinical Oncology, 7(6):754–760PubMedGoogle Scholar
  17. Schweitzer V.G. (1993) Ototoxicity of chemotherapeutic agents. Otolaryngologic Clinics of North America 26(5):759–779PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Colleen Nixon

There are no affiliations available

Personalised recommendations